Biomarkers for Diabetes

Biomarker”, are called “molecular marker” or a “signature molecule”. These viewed as direct or indirect markers of the extent of disease as they lay outside in a casual way. HbA1c is considered a biomarker for a risk factor that is for retinopathy, nephropathy and other vascular diseases. Biomarkers enable preventive measures to be applied at the subclinical stage and the responses to preventive or therapeutic measures to be monitored. Cases over the past two decades have yielded sample sets, mostly blood products and urine from a large category of patients with both type 1 and type 2 diabetes.

  • Carbonyl stress
  • Pulse wave analysis
  • Auto fluorescence
  • Biomarkers of vascular function in diabetes

Related Conference of Biomarkers for Diabetes

March 26-27, 2026

7th Global summit on Diabetes and Endocrinology

Amsterdam, Netherlands
May 14-15, 2026

7th World Summit on Diabetes

Rome, Italy
May 18-19, 2026

57th Annual Congress on Endocrinology and Diabetes Research

Aix-en-Provence, France
June 22-23, 2026

16th World Congress on Endocrinology and Diabetes

Paris, France
August 17-18, 2026

4th World congress and Expo on Diabetes

Toronto, Canada
September 29-30, 2026

22nd World Congress on Endocrinology & Diabetes

Paris, France

Biomarkers for Diabetes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in